Skip to main content
Premium Trial:

Request an Annual Quote

Real or Imagined?

Premium

A new study published in the Journal of Clinical Oncology shows that breast cancer patients may not be correctly judging the quality of the care they get, Reuters' Andrew Seaman reports. "The impressions of breast cancer patients about the quality of care they received often differed from medical definitions of quality — in part because the patients were judging their experiences by a different set of standards," Seaman says. The researchers interviewed 374 women about their care and their trust in their doctors. They found that the majority of the women tended to underestimate the quality of care, Seaman says. In addition, a significantly lower percentage of black women said they got "excellent" care, compared to white or Hispanic women. "[Lead author Nina] Bickell said that it comes down to hospitals, doctors' offices, and other players in the healthcare delivery system to change the culture on the best way to take care of patients," Seaman adds. "That means making it easier for patients to make appointments, get referrals and test results, letting them know what the next steps are and telling the patient what they need to know to make it happen, she said."

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.